24 reports

Asthma is caused by environmental and genetic factors, which can influence how severe asthma is and how well it responds to medication.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Trade

Asthma is caused by environmental and genetic factors, which can influence how severe asthma is and how well it responds to medication.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • GlaxoSmithKline plc

Inhalation and Nasal Spray Generic Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 ##.

  • Cough And Cold
  • Drug Delivery
  • Pulmonary Delivery
  • World
  • Market Size

The auto exports exceeded over ## million each year.

  • Cough And Cold
  • China
  • Demand
  • Forecast
  • Market Size

THE COMPANY MAINLY SELLS DRUGS TREATING HBV, ASTHMAS AND INFECTIONS.

  • Cough And Cold
  • China
  • Supply
  • Shandong Xinhua Pharmaceutical Company Limited
  • Taiji Group

(India) ##.

  • Cough And Cold
  • United States
  • World
  • Demand
  • Market Shares

A US MARKET REPORT ##.

  • Allergy Drug
  • Cough And Cold
  • OTC
  • Pharmaceutical
  • United States
  • Nasopharyngitis (Common Cold)
  • Nasopharyngitis (Common Cold) - Pipeline by Charleston Laboratories Inc, H2 2018

The molecules developed by Companies in Filing rejected/ Withdrawn, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Cough And Cold
  • United States
  • World
  • Company Sales
  • Product Initiative
  • PRODUCT ANALYSIS

The panel expressed concerns over side-effects and the possibility for off-label use for use in asthma patients.

  • Cough And Cold
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Nasopharyngitis (Common Cold)
  • Nasopharyngitis (Common Cold) - Pipeline by Orbis Biosciences Inc, H1 2018

Similarly, the Universities' portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Cough And Cold
  • Respiratory Disease
  • United States
  • World
  • Product Initiative
  • SINUSITIS - PIPELINE BY KNOPP BIOSCIENCES LLC, H1 2018
  • SINUSITIS - PIPELINE BY KYORIN PHARMACEUTICAL CO LTD, H1 2018

In the Phase IIb study, subjects with uncontrolled severe asthma and elevated baseline blood eosinophil levels taking benralizumab had a statistically significant reduction in their asthma exacerbation rate (AER), as well as improvements in lung function (FEV##) and asthma

  • Cough And Cold
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

A US MARKET REPORT ##.

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • Therapy
  • United States
  • Clinical Trial profile. 29 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Cough And Cold
  • Pharmaceutical
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cough And Cold
  • Therapy
  • World
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.
  • Vernalis Plc, Major Products and Services

Vernalis NCE pipeline includes eight programs in development including V## for pain; V## for CNS diseases; AUY##, CHR##, Servier ## and V2006 and V## for cancer; and RPL## for asthma and allergic rhinitis.

  • Cough And Cold
  • Pharmaceutical
  • United States
  • Company Financials
  • Vernalis plc

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Cough And Cold
  • Pharmaceutical
  • World
  • Product Initiative

NO has a solid place in asthma management.

  • Drug Test
  • United States
  • Alere Inc.
  • Dräger Group
  • Thermo Fisher Scientific, Inc.
  • SINUSITIS - PIPELINE BY KYORIN PHARMACEUTICAL CO LTD, H2 2018
  • SINUSITIS - PIPELINE BY KNOPP BIOSCIENCES LLC, H2 2018

In the Phase IIb study, subjects with uncontrolled severe asthma and elevated baseline blood eosinophil levels taking benralizumab had a statistically significant reduction in their asthma exacerbation rate (AER), as well as improvements in lung function (FEV##) and asthma

  • Cough And Cold
  • Hospital
  • Therapy
  • United States
  • Product Initiative

DISCLAIMER DISCLAIMER For information regarding permission, contact: Tel: ##-##-##-## www. marketsandmarkets. com US Toll Free: ##-##-##-##

  • Cough And Cold
  • Drug Delivery
  • North America
  • United States
  • Market Size
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Reddy' s Laboratories Ltd ## ## ## ## ## Merck & Co Inc ## ## ## ## ## Johnson & Johnson ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## Bayer AG ## ## ## ## ## Pfizer Inc ## ## ## ## ## Novartis AG ## ## ## ## ## Lotus Labs Pvt Ltd ## ## ## ## ## C.

  • Cough And Cold
  • Therapy
  • World
  • Product Initiative
  • Dr. Reddy's Laboratories Limited

The prominent features of this report are - ##.

  • Clinical Trial
  • Cough And Cold
  • Drug Discovery And Development
  • World
  • Product Initiative

A US MARKET REPORT ##.

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • Therapy
  • United States
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Cough And Cold
  • Respiratory Disease
  • Therapy
  • World
  • Product Initiative

APPROXIMATELY ## HEALTHY, HIV-UNINFECTED WOMEN AGES ##-## WHO ARE NOT PREGNANT WILL BE RANDOMLY ASSIGNED TO ONE OF THREE GROUPS: ONE GROUP WILL USE A VAGINAL RING DESIGNED FOR THREE-MONTH USE THAT CONTAINS ## MG DAPIVIRINE; ONE GROUP WILL USE A RING ALSO DESIGNED FOR THRE

  • Anesthetics
  • Clinical Trial
  • Cough And Cold
  • Pharmaceutical
  • Opiant Pharmaceuticals, Inc.